0001562180-22-000356.txt : 20220107 0001562180-22-000356.hdr.sgml : 20220107 20220107211831 ACCESSION NUMBER: 0001562180-22-000356 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220106 FILED AS OF DATE: 20220107 DATE AS OF CHANGE: 20220107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Clark George C. CENTRAL INDEX KEY: 0001878290 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38080 FILM NUMBER: 22519452 MAIL ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd. CENTRAL INDEX KEY: 0001689813 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 203-404-0410 MAIL ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2022-01-06 false 0001689813 Biohaven Pharmaceutical Holding Co Ltd. BHVN 0001878290 Clark George C. C/O BIOHAVEN PHARMACEUTICALS, INC. 215 CHURCH STREET NEW HAVEN CT 06510 false true false false VP, Chief Accounting Officer Common Shares 2022-01-06 4 M false 875.00 0.00 A 9115.00 D Common Shares 2022-01-06 4 F false 409.00 123.86 D 8706.00 D Common Shares 2022-01-07 4 M false 1000.00 0.00 A 9706.00 D Common Shares 2022-01-07 4 F false 522.00 128.87 D 9184.00 D Restricted Share Unit Award 2022-01-06 4 M false 875.00 0.00 D Common Shares 875.00 1750.00 D Employee Stock Option (right to buy) 128.87 2022-01-07 4 A false 10000.00 0.00 A 2032-01-07 Common Shares 10000.00 10000.00 D Restricted Share Unit Award 2022-01-07 4 A false 5000.00 0.00 A Common Shares 5000.00 5000.00 D Restricted Share Unit Award 2022-01-07 4 M false 1000.00 0.00 D Common Shares 1000.00 4000.00 D No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units. Each restricted share unit represents the contingent right to receive one common share of the Issuer. The reporting person was granted 3,500 restricted share units on January 6, 2021, vesting in four equal installments on January 6, 2021, 2022, 2023 and 2024, subject to the reporting person's continued service with the Issuer at each vesting date. Not applicable. The shares underlying this option vest in four equal installments on January 7, 2022, 2023, 2024 and 2025, subject to the reporting person's continuous service with the Issuer at each vesting date. The reporting person was granted 5,000 restricted share units on January 7, 2022, vesting in four equal installments on January 7, 2022, 2023, 2024 and 2025, subject to the reporting person's continued service with the Issuer at each vesting date. 100% of these restricted share units are generally subject to settlement in 10 equal annual installments after separation from service. /s/ George Clark 2022-01-07